BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Clinical Outcome
7 results:

  • 1. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
    Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
    Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.
    Edmondson RJ; Crosbie EJ; Nickkho-Amiry M; Kaufmann A; Stelloo E; Nijman HW; Leary A; Auguste A; Mileshkin L; Pollock P; MacKay HJ; Powell ME; Bosse T; Creutzberg CL; Kitchener HC
    Gynecol Oncol; 2017 Aug; 146(2):327-333. PubMed ID: 28511869
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology.
    Layfield LJ; Liu K; Dodge R; Barsky SH
    Arch Pathol Lab Med; 2000 Feb; 124(2):221-7. PubMed ID: 10656730
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma.
    Pillai MR; Jayaprakash PG; Nair MK
    J Cancer Res Clin Oncol; 1999; 125(1):55-60. PubMed ID: 10037278
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
    Kurvinen K; Syrjänen K; Syrjänen S
    J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. p53 mutation and mdm2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.